✦ LIBER ✦

Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget’s disease

✍ Scribed by Si-Yuan Chen; Yoichi Moroi; Kazunori Urabe; Satoshi Takeuchi; Makiko Kido; Sayaka Hayashida; Hiroshi Uchi; Takeshi Uenotsuchi; Ya-Ting Tu; Masutaka Furue

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 529 KB
Volume: 300
Category: Article
ISSN: 0340-3696
DOI: 10.1007/s00403-008-0829-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIG7/LITAF gene mutation and overexpress

PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease

✍ Yasuhiro Matsumura; Yumi Matsumura; Chikako Nishigori; Takeshi Horio; Yoshiki Mi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 159 KB 👁 1 views

## Abstract To identify cancer‐related genes that are involved in the carcinogenesis of extramammary Paget's disease (EMPD), we compared mRNA expression profiles of EMPD lesions and corresponding normal skin using cDNA array. Sixty‐eight genes were highly expressed (>5‐fold) in EMPD lesions compare

Overexpression of p2lWaf1/Cip1 immunohis

Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis

✍ Kawakami; Saito; Takahashi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Mitogen- and stress-activated protein ki

Mitogen- and stress-activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease

✍ Kate M. Webber; Mark A. Smith; Hyoung-gon Lee; Peggy L. Harris; Paula Moreira; G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 1 views

## Abstract Two of the earliest manifestations of the selective neurodegeneration that occurs in Alzheimer's disease (AD) involve the oxidative modification of various biomacromolecules and the reexpression of a multitude of cell cycle‐related proteins. Taken together with the proximal and ectopic

Role of Erk1/2, p70s6K, and eNOS in isof

Role of Erk1/2, p70s6K, and eNOS in isofluraneinduced cardioprotection during early reperfusionin vivo

✍ John G. Krolikowski; Dorothee Weihrauch; Martin Bienengraeber; Judy R. Kersten; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 French ⚖ 217 KB

Genetic Epidemiology of Paget’s Disease

Genetic Epidemiology of Paget’s Disease of Bone in Italy: sequestosome1/p62Gene Mutational Test and Haplotype Analysis at 5q35 in a Large Representative Series of Sporadic and Familial Italian Cases of Paget’s Disease of Bone

✍ Alberto Falchetti; Marco Di Stefano; Francesca Marini; Sergio Ortolani; Massimo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 584 KB

Use of etidronate (ehdp) in paget's dise

Use of etidronate (ehdp) in paget's disease of bone

✍ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients